Passive cards claimed to 'store' electromagnetic 'information / frequencies' and deliver healing when worn on the body — no active device, no measurement, no dose. The passive-carrier subtype of informational medicine: a stronger, more clearly contradicting claim than the base measure-and-return bioresonance device (which the atlas grades T2). Homeopathy-of-EM; a patent is existence, not efficacy.
SI cards — “system information” or bioinformation cards — are passive cards claimed to “store” electromagnetic “information / frequencies” and to deliver healing simply by being worn on the body. They sit in the Information / Bioresonance family, and they are its passive-carrier subtype: no active device, no measurement, no dose. The documented product class is the SI “Med Select” card (Wegamed); RU / Eastern variants under the names MVI / Majerič appear in the seed material. The card is a real physical object, and the device class is even patented — but the claim that a passive card holds and delivers therapeutic “information” has no mechanism.
Two facts here are genuine, and neither supports the doctrine. First, the card is a real physical object. Second, the class is patented — US patent 10941061, a “therapeutic frequency imprinting device.” What is claimed on top is that the card “holds” curative “frequency information,” with a “magnetic field around the card,” that acts on cells when worn. There is no active emission, no measurement, and no dose — and no mechanism by which a passive carrier could store and then deliver therapeutic “information” to tissue. This is the atlas's standard split taken to its extreme: ordinarily we keep an instrument and a measurement while setting aside the interpretation, but here there is no instrument and no measurement to keep — only the object and the patent. It is, in effect, a homeopathy-of-electromagnetism.
The claim — that a passive card stores and delivers therapeutic “frequency information” — has no mechanism, and that is the heart of the grade: there is no known physical channel for a card to retain a curative “frequency” and impose it on cells through proximity. This is not a measurement awaiting a cleaner reading; it is a claim with nothing to read. The single anchor below is the US patent — included precisely to make the point that a patent is existence, not efficacy: it attests that a design was filed and described, not that it works. The named RU / Eastern brand MVI / Majerič is seed-only: beyond vendor and fringe channels there is no independent external documentation of it at all — and for a fringe item, that absence is itself an informative finding. The grade is E/F: no mechanism, no independent evidence.
SI cards land in the strong-rejection tier on the contradicts-established-science axis (T3), and the instructive comparison is with their own family base. Bioresonance devices (BICOM, MORA, IMEDIS) grade T2 in this atlas — not because the theory is sound, but because they are at least an instrument with a measurement: a device that reads something and returns a signal. The passive card has neither. It is the same idea stripped of the apparatus, so the claim is weaker still — no instrument, no measurement, no dose — and the tier sits below the base bioresonance device accordingly. Keep the axes separate: the card is a real object (plausible as a thing), the patent is real (existence), and the therapeutic claim still grades E/F (contradicts). Patent and object are not evidence for the cure.
There is no medical clearance for SI cards as a treatment in any jurisdiction — no FDA, EU-MDR, NMPA, or TGA authorisation. The one regulatory-adjacent fact is the US patent (10941061) covering the class, and it must not be misread as one: a patent is an intellectual-property fact about a filed design, not a clearance and not efficacy. The cards are sold as consumer wellness. As elsewhere in this atlas, patent status is existence at most, never efficacy.
SI cards sit at the most stripped-down corner of the same transnational “information-field” cluster mapped across this atlas. The most informative neighbour is bioresonance — the instrument-with-a-measurement base from which the passive card is the weaker descendant. Beyond it lie scalar-wave devices and “quantum-healing” branding, the field-transfer chambers of Kozyrev Mirrors, and the water variant structured water. See where these ideas come from. The card simply removes every part except the carrier.
Keep: the card as a real physical object, and the fact that the device class is patented. Set aside: the claim that a passive card stores and delivers therapeutic “frequency information” — it has no mechanism, no measurement, and no independent documentation. It is the passive-carrier extreme of informational medicine, and its tier sits below base bioresonance precisely because the claim is weaker still.
Registration or clearance is a market-access fact, never proof of efficacy.
| US — FDA | None as a medical treatment; the device class is patented (US 10941061) — patent ≠ efficacy / ≠ clearance. |
|---|---|
| EU — MDR | None as a medical treatment. |
| Russia | None as a medical treatment. |
| China — NMPA | None. |
| Australia — TGA | None. |
Anchor (existence, not efficacy): US patent 10941061 'therapeutic frequency imprinting device' (a patented class — patent ≠ efficacy). Documented product class = SI 'system information' cards (Wegamed 'Med Select'). The named RU/Eastern brand MVI / Majerič is seed-only — no independent external documentation beyond vendor / fringe channels, itself an informative finding for a fringe item.